EpiEndo Pharmaceuticals
Clinical biopharmaceutical company focused on novel solutions for chronic airway diseases.
2
Funding Rounds
$3.1m
Money raised
Funding series
Funding Series Analysis
The company EpiEndo Pharmaceuticals has raised a total of $3.11m in funding over 2 rounds.
Key Insights:
- EpiEndo Pharmaceuticals December 2019 Seed Funding Round: $2.2m
- EpiEndo Pharmaceuticals January 2019 Pre-Seed Funding Round: $910k
EpiEndo Pharmaceuticals December 2019 Seed Funding Round
$2.2m
EpiEndo Pharmaceuticals January 2019 Pre-Seed Funding Round
$910k
Industries
EpiEndo Pharmaceuticals is active in the following industries: